Despite concerns about the possible community circulation of the Delta variant of the coronavirus, the Minister of Health, Carla Vizzotti, was optimistic and pointed out this Saturday morning that “We are closer than ever to a definitive exit.”
The head of the health portfolio explained that it is partly due to the progress in the vaccination campaign and because “there is no predominant circulation of the Delta variant in the country. “ He specified: “We have the Manaos, the United Kingdom and the Andean”.
Regarding the combination of vaccines, which could accelerate the second doses and thus better prepare the population for the Delta variant, Vizzotti explained, in dialogue with Radio 10: “We are doing studies with the City of Buenos Aires, province of Buenos Aires, with 4 more provinces, Corrientes, Córdoba, Mendoza and San Luis. We assume that next week we will have local data“.
Then, the minister pointed out to the Argentines who left the country during the pandemic: “Travel abroad should be discouraged, is a health risk. We implement control measures, we speak with the jurisdictions so that they intensify the care, but for the National State it is impossible to control in each house in each province. You have to work together with the other provinces and each of the municipalities and also with society. “
Regarding the inoculation of the population, he expressed: “We hope to reach 60% of those over 50 years vaccinated with the two doses in August.”
“Let’s go 75% of those over 18 who started their scheme90% of those over 50, and 50% of those over 70 have already completed their vaccination schedule ”, Vizzotti explained.
The Ministry headed by Vizzotti carries out a trial in which different anticovid vaccines are combined with the aim of authorizing heterologous vaccination schedules against the coronavirus, that is, the possibility of applying vaccines to people from different laboratories.
“The data that have been obtained in the world in the combination of vaccines (Sputnik – AstraZeneca) are very good“said the minister on Saturday.
And he added: “Surely next week we will have data from local studies between Sputnik-Moderna and Sputnik-Sinopharm“.
The study in question is “collaborative and federal”, and is coordinated with the participating jurisdictions (Buenos Aires, Córdoba, La Rioja, Mendoza and San Luis) and researchers from the National Council for Scientific and Technical Research (Conicet).
Scientific work seeks to “have national evidence for decision making from the immunogenicity and safety analysis of the use of different doses in the same scheme “, according to an official statement.
Until now, the dose combinations of AstraZeneca, the Chinese Sinopharm and the Russian Sputnik V were under study, the latter being the one with the longest delay for second applications. And in a second moment Moderna’s vaccine was added to the trials.
Regarding the expected arrival of second doses of the Russian vaccine, the official remarked: “Next week 300 more liters of component 2 of Sputnik V will be arriving and we hope that with that, at the end of August, let’s have 1 and a half million second doses“.